SYNOPSIS A specific method of estimating pyruvate, depending upon the oxidation of reduced nicotinamide-adenine dinucleotide in the presence of lactic dehydrogenase, has been modified to improve its accuracy. The precision of the modification, measured by duplicate analysis, was represented by a standard deviation of 0-03 mg./100 ml. The mean recovery of added pyruvate was 99 %.
Pyruvic acid occupies a central position in intermediary metabolism, and its level in the blood is affected by many conditions. It is important that a specific and relatively rapid method for its measurement in biological solutions should be available.
The most commonly used methods of measuring pyruvate depend upon its condensation with 2,4-dinitrophenylhydrazine. Several modifications have been developed (Barrenscheen and Dreguss, 1931; Lu, 1939; Bueding and Wortis, 1940; Klein, 1941; Bonting, 1955) , the most popular being that of Friedemann and Haugen (1943) . These methods, however, are not specific because the results are variably affected by other ox-keto acids.
Paper chromatography of the hydrazones of the ao-keto acids was introduced by Cavallini, Frontali, and Toschi (1949) for the specific measurement of pyruvate and has been used by several other workers, including Seligson and Shapiro (1952) , El Hawary and Thompson (1953), and McArdle (1957) . This step, however, is time consuming and may result in loss of some of the pyruvic acid hydrazone.
Specific and more rapid methods for measuring pyruvate have been introduced. These depend upon the oxidation of reduced nicotinamide-adenine dinucleotide (NADH) The oxidation of nicotinamide-adenine dinucleotide is measured spectrophotometrically by the change in extinction at its peak absorption of 340 rn,u.
The reaction between pyruvic acid and reduced nicotinamide adenine dinucleotide is stoichiometric. Since the equilibrium of this reaction lies far to the right (Kubowitz and Ott, 1943) , the fall in extinction is proportional to the pyruvate concentration. Hess (1955) added reduced nicotinamide-adenine dinucleotide to serum and made use of the serum lactic dehydrogenase present. Other workers (Bauer, 1956; Redetzki, Bloedorn, and Bansi, 1956; Segal, Blair, and Wyngaarden, 1956 ) deproteinized blood immediately to inactivate its lactic dehydrogenase, and later established a buffer system with a pH of about 6 and added reduced nicotinamide-adenine dinucleotide and then lactic dehydrogenase to promote the reaction.
The purpose of the present paper is to report some observations on the nicotinamide-adenine dinucleotide reaction for the measurement of blood pyruvic acid. The levels in control subjects while fasting and after oral or using the sensitivity control for the zero extinction reading. The measurement was made against an arbitrary blank of 3 ml. of deionized water containing 001 to 0-02 ml. of reduced nicotinamide-adenine dinucleotide.
Exactly 003 ml. of lactic dehydrogenase solution2 (0 75 mg./ml.) was mixed with the test solution by inversion, after sealing the cuvette again with parafilm. Extinction readings against the same blank were recorded after 90 seconds and 120 seconds.
Blank and standard measurements were made in exactly the same way by substituting deionized water, and a standard pyruvic acid solution for blood in the above procedure.
The blank measurement, which was about 0-012, was subtracted from those of standards and unknown. As the reaction between pyruvic acid and reduced nicotinamide adenine dinucleotide is stoichiometric, the pyruvic acid concentration was proportional to the corrected fall in extinction. With the Unicam SP500 spectrophotometer used, an extinction change of 0-100 corresponded to a concentration of 0-60 mg. of pyruvate per 100 ml. of blood. Two corrections, however, were applied. As 3 ml. of blood contained only about 2 54 ml. of water, the volume of solution after deproteinization was 8-54 ml. instead of 9 ml., and therefore the observed result was 8-54 multiplied by . Also 3 % was added to the observed result to correct as closely as possible for the loss of pyruvate (Huckabee, 1956) in the one-minute interval between withdrawing and deproteinizing the blood. These two corrections were incorporated into the factor for converting extinction values to pyruvate concentration.
OBSERVATIONS ON THE METHOD
The solutions of reduced nicotinamide-adenine dinucleotide and lactic dehydrogenase were obtained in a test kit, but the method described here differs in several ways from that supplied with the reagents. These differences are summarized below, and the reasons for introducing them are discussed. 1 Blood, 3 ml., was deproteinized with 6 ml. instead of 3 ml. of 0-6 M perchloric acid. This was to ensure more complete deproteinization and to provide enough supernatant solution for duplicate analyses. The concentration of the dipotassium hydrogen phosphate solution was raised from 1 1 M to 1-5 M to produce the same pH in the buffer system as that which resulted when the smaller volume of perchloric acid was used.
2 The concentrations of reduced nicotinamideadenine dinucleotide and lactic dehydrogenase in the cuvettes were decreased by 60 %, and a blank determination was included with each series of unknowns. These changes were made because of the errors due to the fall in extinction which resulted from dilution of the reduced nicotinamide-adenine 2C. F. Boehringer and Soehne, Mannheim, Germany: Pyruvate testkit TC-C. dinucleotide by the added lactic dehydrogenase, in addition to the fall resulting from its oxidation. This was particularly large using the volume of reagents proposed by the suppliers, especially as the concentration of nicotinamide-adenine dinucleotide was found to be three times as great as that stated. Using the volumes stated above, neglecting to correct for the dilution of nicotinamide-adenine dinucleotide would have caused errors of about 0 07 mg./100 ml. The introduction of a blank assay corrected for the dilution effect but errors could still result from'small variations in the volume of enzyme solution added. The reduction in the volume of each of the two reagents used did not impair the ability of the method to measure even quite high levels of pyruvate and produced a corresponding reduction in the errors which could arise from unreproducibility of volume measurement. The reduced nicotinamide-adenine dinucleotide available was equivalent to about 3-5 mg. of pyruvic acid per 100 ml. of blood, and the equilibrium constant of the reaction favoured maximum utilization. Accurate results were obtained on standard solutions corresponding to 3 mg. per 100 ml. of blood. If necessary for the measurement of higher levels, the deproteinized blood can be diluted with 0-4 M perchloric acid before adding phosphate.
3 Volumes were adjusted to provide the 3 ml. of solution required by the 10 mm. cuvettes of the Unicam SP500 spectrophotometer, and an instrument blank was prepared by diluting 0-01 to 0-02 ml.
of the nicotinamide-adenine dinculeotide solution in 3 ml. of water. This avoided using the less accurate regions of the extinction scale for the measurement of changes in extinction. 4 A standard was included with each series of unknowns, and in all cases readings were taken 15 minutes, as well as two minutes, after adding the enzyme. These precautions were included to check the reagents and confirm that the reaction proceeded at its usual rate. When the correct values for the results of blank and standard assays had been established on numerous occasions, they were then used as a check on the performance of the method subsequently. The extinction readings two minutes after adding lactic dehydrogenase were not more than 0 003 lower than the readings 15 minutes after the addition. Larger differences usually indicated contamination of reagents, and the purpose of the 1-5 minute reading was to check that the reaction was by then almost complete. This was less timeconsuming than taking several readings at oneminute intervals after two minutes, as others have suggested.
We found that inadequate cooling of the blood during deproteinization with perchloric acid resulted in loss of pyruvic acid, due to persistence of lactic dehydrogenase activity until deproteinization was complete. Once deproteinization was completed, however, the pyruvate in the supematant solution was stable for at least 24 hours, as demonstrated below. Single analyses were made on each of 17 blood samples. The residual deproteinized solution was left in the centrifuge tube in contact with the precipitated protein, and a second portion was used for analysis the following day. The result on the second day was not significantly different, being an average of 0-01 mg./100 ml. higher than on the first day. The mean difference, ignoring sign, and the standard deviation calculated from these data, were each 0-04 mg./100 ml., similar in fact to the values reported below for duplicates carried out both on the same day.
Errors also resulted if the temperature of the solution was allowed to exceed 5°C during the precipitation of potassium perchlorate, or if the deproteinized blood was not cooled before adding the phosphate. Thus, if the temperature was 80, 10% of the pyruvate was lost even within the minimum precipitation period of 10 minutes. This was thought to be due to renewed lactic dehydrogenase activity at higher temperatures, after the precipitation of the perchlorate, as the losses occurred with blood samples but not with standard solutions. Provided the temperature of the solution was kept below 5°d uring precipitation of potassium perchlorate, a delay of 60 minutes did not significantly alter the level of pyruvate.
The precision of the method was investigated by inspecting the results of duplicate analyses. These are reported in Table I for each of three analysts and show a standard deviation for the method of 0 03 mg./100 ml. Single analyses on 13 samples were carried out by two analysts each of whom was unaware of the other's results. The mean result was the same for each analyst, indicating the absence of any systematic difference. Disregarding the sign of each difference, random errors yielded a standard deviation of 0 04 mg./100 ml., no greater than that obtained when one of the analysts made both measurements.
In carrying out recovery experiments, standard pyruvic acid was not added to blood before it had been mixed with perchloric acid, because of the consequent losses which would have occurred. In eight experiments, therefore, pyruvic acid was added to one of two portions of perchloric acid, to each of which portions of blood were then added simultaneously. The amount added corresponded to an increment of 1 mg. per 100 ml. of blood. The mean recovery was 99% and the standard deviation was 4%.
OBSERVATIONS ON THE COLLECTION OF SAMPLES
Venepuncture is facilitated by warming the hand, repeated hand clenching, or venous occlusion. As importance is often attached to the avoidance of artefacts which might influence the pyruvate concentration during the collection of blood, the effect of each of these was investigated in fasting and nonfasting subjects.
In seven experiments the skin temperature of one hand was heated to 5 to 10°C. above the temperature of the other, for at least 30 minutes, and blood was taken simultaneously from the antecubital fossa of each arm. The blood pyruvate concentration for the heated arm was an average of 0-01 mg./100 ml. lower than that for the other (S.D. 0 07 mg./100 ml.) and this difference was not statistically significant (0 1 <P). In only two of the seven experiments was the difference greater than 0 03 mg./100 ml.
In seven other experiments, blood pyruvate concentration was measured before and immediately following a period of 40 to 80 seconds of fist clenching performed at the rate of one clench per second. The pyruvate concentration in the second sample was an average of 0-08 mg./100 ml. higher than in the first (S.D. 0-10 mg./100 ml.). The mean change was not statistically significant (005<P<0 1) and the degree of change did not appear to be related to the variation in clenching time.
In a further nine experiments the blood pyruvate concentration was measured before and after three minutes of venous occlusion by means of a sphygmomanometer cuff around the upper arm adjusted to a pressure midway between the patient's systolic and diastolic blood pressure. The pyruvate concentration in the second sample was an average of 0 01 mg./ 100 ml. lower than in the first sample (S.D. 0-11 mg./ 100 ml.) and this difference was not statistically significant (0-1 < P).
RESULTS

BLOOD PYRUVATE CONCENTRATION IN FASTED SUB-
JECTS The pyruvate concentration was estimated in 75 venous blood samples from 30 fasted subjects. The mean level was 044 mg./100 ml. (S.D. 0-05) with a range of 0-36 to 0-59 mg./100 ml. In subjects for whom several results were obtained, the variability for the individual was as great as the variability between individuals. The results showed no significant difference between the sexes, the mean value being 0-46 mg./100 ml. for the men, and 0.43 mg./100 ml. for the women. There was no 110  75  110  74  112  75   120  105  80  105  98  118  108  60  112 significant variation of the venous blood levels of pyruvate with age. The mean value for the seven subjects under 25 years of age was the same as for the 11 subjects over 50 years of age, namely, 0-46 mg./ 100 ml., while the mean blood pyruvate level for the remaining 12 subjects, between 25 and 50 years of age, was 0-42 mg./100 ml.
EFFECT OF ORAL GLUCOSE ON BLOOD PYRUVATE CON-CENTRATION Glucose was given orally to 15 fasted subjects and the venous blood pyruvate and sugar levels were measured at 30-minute intervals for two hours. The results are reported in Table II . In all cases the oral glucose tolerance curve was within normal limits.
The mean blood pyruvate curve for these 15 subjects is shown in Fig. 1 . From a mean fasting level of 0 43 mg./100 ml. the mean pyruvate level rose by nearly 100% to 0-85 mg./100 ml. and then fell to 0-71 mg./100 ml. two hours after glucose administration. The highest level of blood pyruvate found was 60 minutes after glucose administration in six subjects, after 90 minutes in eight subjects, and after 120 minutes in the remaining subject.
EFFECT OF INTRAVENOUS GLUCOSE ON BLOOD PYRUVATE
CONCENTRATION Glucose was given to 15 fasted subjects by intravenous injection. Venous blood samples were taken at 30-minute intervals for two hours for the measurement of pyruvate and at 15-minute intervals for two hours for the measurement of sugar. The results reported in Table III show that intravenous glucose tolerance was normal in all cases.
The mean blood pyruvate curve for these 15 subjects is shown in Fig. 2 . From a fasting level of 0 43 mg./100 ml. the mean pyruvate level rose by nearly 100% to 0-82 mg./100 ml. and then fell to 0 50 mg./100 ml. two hours after glucose administration. The highest level of blood pyruvate was found 30 minutes after glucose administration in eight subjects and after 60 minutes in the remaining seven subjects.
DISCUSSION
The measurement of pyruvate as its hydrazone gives higher values than those obtained using specific methods, as the hydrazones of other x-keto acids are also partially measured (Bauer, 1956) . Thus, using a hydrazone method, Bueding and Wortis (1940) Several workers (Bueding, Wortis, and Fein, 1942; Klein, 1942; Bueding and Goldfarb, 1943; Joiner, McArdle, and Thompson, 1950; Shrifter and Kritzer, 1956 ) found a transient rise in the blood pyruvate concentration after glucose loading, and found abnormalities of the pyruvate curve after glucose in several diseases, for example, diabetes mellitus and thiamine deficiency. These workers used non-specific hydrazone methods for the measurement of the blood pyruvate. The pyruvate levels after glucose have also been measured by a more specific chromatographic modification (Thompson, Butterfield, and Fry, 1960; McArdle, Mackenzie, and Webster, 1960 
